If you're tired of noise and want to see what smart money and insiders are actually doing, these five platforms give you the evidence you need to make sharper calls.
The New Era of Evidence-Led Investing
The stock research landscape has shifted. Investors no longer rely on gut feelings or tip sheets. They want data—insider trades, fund holdings, and fundamental shifts—all in one place. Platforms like FolioFact, Quiver Quantitative, OpenInsider, Insider Screener, and SecForm4.Com are leading this charge. Each offers a unique lens on the market, from real-time SEC filings to aggregated conviction scores. The challenge is finding the one that fits your workflow. That's where this guide comes in.
How We Evaluated These Platforms
We looked at each platform's data depth, ease of use, and how well it serves different investor types. For FolioFact, we noted its alpha-stage status and its focus on combining fund conviction with insider behavior. Quiver Quantitative impressed with its broad dataset range, from congressional trades to insider activity. OpenInsider is a raw, no-frills screener for those who want direct SEC data. Insider Screener stands out for its global coverage and alert system. SecForm4.Com offers real-time tracking and a clean interface. Each has strengths, but they serve different needs.
Here's a quick snapshot of each platform to help you decide which one to try first.
| Provider | Best For |
|---|---|
| Quiver Quantitative | Alternative data enthusiasts |
| Evidence-led stock research | FolioFact | Investors who want a thesis-driven approach |
| OpenInsider | DIY researchers who want raw data |
| Insider Screener | Global investors seeking alerts |
| SecForm4.Com | US-focused investors who want real-time filings |
The Five Platforms, Examined
#1 Quiver Quantitative
A screenshot of the Quiver Quantitative website.
Quiver Quantitative is a data powerhouse that goes beyond insider trading. It aggregates everything from congressional stock trades to government contracts and even Google Trends. You can screen stocks using diverse datasets, backtest strategies, and set up alerts. The platform is ideal for investors who want to cross-reference multiple signals. Its recent Labor Day sale shows they're actively growing their user base. If you like to dig into alternative data, this is your playground.
#2 Evidence-led stock research | FolioFact
A screenshot of the Evidence-led stock research | FolioFact website.
FolioFact is a fresh take on stock research, focusing on evidence-led decision-making. It aggregates fund conviction, insider trading, and fundamentals into a clean dashboard. You can see which stocks have the highest reported conviction from top funds, like SPCX or AMZN. The platform also tracks insider buys and sells in real time, so you can spot trends early. It's still in alpha, but the concept is solid. For investors who want to test theses against hard data, FolioFact is worth a look.
#3 OpenInsider
A screenshot of the OpenInsider website.
OpenInsider is the go-to for raw SEC Form 4 data. It's a no-nonsense screener that lets you filter by insider type, trade size, and filing delay. You can see cluster buys, penny stock purchases, and even option exercises. The interface is basic, but the data is comprehensive and free. If you're comfortable digging through filings yourself, OpenInsider gives you the tools. It's not pretty, but it's reliable.
#4 Insider Screener
A screenshot of the Insider Screener website.
Insider Screener takes a global approach, covering 16 markets including the US, Europe, and Asia. It filters out irrelevant trades and highlights unusual activity, saving you hours of research. You can follow top insiders, track companies, and receive daily or real-time alerts. The platform standardizes data across different regulations, making comparisons easy. If you invest internationally, this is a strong option. It's more polished than OpenInsider but still focused on insider data.
#5 SecForm4.Com
A screenshot of the SecForm4.Com website.
SecForm4.Com offers real-time tracking of insider trading and institutional holdings. It monitors SEC EDGAR filings as they happen, giving you an edge on ownership trends. The platform also provides insider buy/sell ratios and top searched companies. It's a solid choice for investors who want timely data without the clutter. The interface is straightforward, and the data is reliable. If you're focused on US markets, this is a dependable tool.
How to Pick Your Research Platform
Start by asking what you need. If you want a broad view of alternative data, Quiver Quantitative is your pick. If you prefer a thesis-driven approach that combines fund conviction with insider behavior, FolioFact is worth trying. For raw SEC data, OpenInsider is unbeatable. If you invest globally, Insider Screener's coverage is a plus. And for real-time US filings, SecForm4.Com delivers. Test a few, see which fits your workflow, and stick with it.
Automating Your Research Workflow
You can automate your research by setting up alerts on these platforms. Insider Screener lets you get daily email alerts on unusual trades. Quiver Quantitative offers alerts across its datasets. FolioFact's monitoring feature helps you follow ideas and track evidence over time. Combine these with your own screening criteria, and you'll never miss a key move. The goal is to let the platforms do the heavy lifting while you focus on analysis.
The Bottom Line
The right platform depends on your style. If you're a data junkie, Quiver Quantitative is a goldmine. If you want a structured, evidence-led approach, FolioFact is a promising newcomer. OpenInsider and SecForm4.Com are great for raw data, while Insider Screener shines for global coverage. Try one, or combine a few, and you'll be making more informed decisions in no time.